Table 1.

Patient characteristics

Patient	ECLS device	ECLS cannulation (VV or VA)	ECLS indication	Changes in vital signs	Changes in ECLS flow rate	Time to move the patient into/out of the pMRI (minutes)	MRI time to obtain the images (minutes)	Staff satisfaction (1 = fully satisfied; 5 = not satisfied
1	Medos Deltastream circuit with a DP3 pump, and a hilite 800 LT oxygenator system, Xenios AG, Aachen, Germany	VV (13 French jugular double lumen cannula; Avalon Elite, Getinge, Rastatt, Germany)	Lung hypoplasia due to multicystic dysplastic kidneys	None	None	25/15	35	2
2	Medos Deltastream circuit with a DP3 pump, and a hilite 2400 LT oxygenator system, Xenios AG, Aachen, Germany	VV (14 French jugular and 14 French femoral single lumen cannula; Medtronic, Minneapolis, MN, USA)	ARDS due to Respiratory syncytial virus	None	None	18/10	25	1
3	Medos Deltastream circuit with a DP3 pump, and a hilite 7000 LT oxygenator system, Xenios AG, Aachen, Germany	VV (17 French jugular and 17 French femoral single lumen cannula; Medtronic, Minneapolis, MN, USA)	ARDS due to Influenza A	None	None	12/8	18	1
4	Medos Deltastream circuit with a DP3 pump, and a hilite 7000 LT oxygenator system, Xenios AG, Aachen, Germany	VA (15 French jugular and 19 French femoral venous and 15 French femoral arterial single lumen cannula; Medtronic, Minneapolis, MN, USA)	Cardiogenic shock due to Parvovirus B19 associated cardiomyopathy	None	None	15/10	22	1

Patients were treated with either veno-venous (VV) or veno-arterial (VA) ECLS

ARDS acute respiratory distress syndrome